Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ra Medical Systems Inc (RMED)

Ra Medical Systems Inc (RMED)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 20,348
  • Shares Outstanding, K 2,919
  • Annual Sales, $ 7,200 K
  • Annual Income, $ -56,960 K
  • 60-Month Beta 1.62
  • Price/Sales 1.69
  • Price/Cash Flow N/A
  • Price/Book 0.67
Trade RMED with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -2.45
  • Number of Estimates 1
  • High Estimate -2.45
  • Low Estimate -2.45
  • Prior Year -18.00
  • Growth Rate Est. (year over year) +86.39%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.37 +9.42%
on 01/06/21
9.47 -26.40%
on 12/21/20
-0.26 (-3.60%)
since 12/15/20
3-Month
4.25 +64.00%
on 11/03/20
9.47 -26.40%
on 12/21/20
+0.41 (+6.25%)
since 10/15/20
52-Week
4.25 +64.00%
on 11/03/20
67.20 -89.63%
on 01/31/20
-43.78 (-86.27%)
since 01/15/20

Most Recent Stories

More News
Ra Medical Systems to Present at H.C. Wainwright Virtual BioConnect Conference

Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, announces that management will...

MDSY : 0.73 (+4.29%)
RMED : 6.97 (-1.55%)
The Law Offices of Frank R. Cruz Continues Its Investigation of Ra Medical Systems, Inc. (RMED) on Behalf of Investors

, /PRNewswire/ --  continues its investigation of potential claims against the board of directors of Ra Medical Systems, Inc. ("Ra Medical" or the "Company") (NYSE: RMED) concerning whether the board...

RMED : 6.97 (-1.55%)
Ra Medical Systems, Inc. (RMED) Reports Q2 Loss, Tops Revenue Estimates

Ra Medical Systems, Inc. (RMED) delivered earnings and revenue surprises of -152.94% and 125.00%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?...

RMED : 6.97 (-1.55%)
Ra Medical Systems Inc (RMED) Reports Q1 Loss, Misses Revenue Estimates

Ra Medical Systems Inc (RMED) delivered earnings and revenue surprises of -166.67% and -9.01%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?...

RMED : 6.97 (-1.55%)
Ra Medical Systems Appoints Joan Stafslien to its Board of Directors

Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological diseases, announces the appointment of Joan Stafslien...

RMED : 6.97 (-1.55%)
NUVA : 56.96 (-2.57%)
The Zacks Analyst Blog Highlights: Eloxx Pharmaceuticals, BGC Partners, SharpSpring, Ra Medical Systems and American States Water

The Zacks Analyst Blog Highlights: Eloxx Pharmaceuticals, BGC Partners, SharpSpring, Ra Medical Systems and American States Water

AWR : 81.37 (+1.06%)
BGCP : 3.80 (-1.55%)
SHSP : 18.77 (+0.37%)
ELOX : 4.13 (-1.20%)
RMED : 6.97 (-1.55%)
5 Stocks to Gain the Most With the Economy Set to Reopen

These five stocks are poised to grow with the guidelines laid out to reopen the economy, as coronavirus pandemic dissipates.

AWR : 81.37 (+1.06%)
BGCP : 3.80 (-1.55%)
SHSP : 18.77 (+0.37%)
ELOX : 4.13 (-1.20%)
RMED : 6.97 (-1.55%)
Ra Medical Systems Appoints Medtech Executive Will McGuire as CEO and Director

Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, announces the appointment of Will McGuire...

MHMNF : 54.5000 (unch)
RMED : 6.97 (-1.55%)
EYES : 1.7100 (-2.84%)
Ra Medical Systems Announces Substantial Completion of Audit Committee Investigation

Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, today announced that the Audit Committee...

MDSY : 0.73 (+4.29%)
RMED : 6.97 (-1.55%)
RMED LOSS NOTICE: ROSEN, A LEADING LAW FIRM, Announces Investigation of Breaches of Fiduciary Duties By Management of Ra Medical Systems, Inc. - RMED

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential breaches of fiduciary duties by the management of Ra Medical Systems, Inc. (NYSE: RMED) resulting from allegations...

MDSY : 0.73 (+4.29%)
RMED : 6.97 (-1.55%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Ra Medical Systems, Inc. is a commercial-stage medical device company. It develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company's product pipeline consists of DABRA which is a minimally-invasive excimer laser and disposable catheter...

See More

Key Turning Points

3rd Resistance Point 7.54
2nd Resistance Point 7.36
1st Resistance Point 7.17
Last Price 6.97
1st Support Level 6.79
2nd Support Level 6.61
3rd Support Level 6.42

See More

52-Week High 67.20
Fibonacci 61.8% 43.15
Fibonacci 50% 35.72
Fibonacci 38.2% 28.30
Last Price 6.97
52-Week Low 4.25

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar